Clinical Trial Update: Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on 5-ALA hydrochloride for fluorescence-guided resection of malignant gliomas (Phase 1/Phase 2), now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• 5-aminolevulinic acid hydrochloride (5-ALA hydrochloride) (5-aminolevulinic acid hydrochloride)

Snippet

Sponsor: medac GmbH | Conditions: Brain Neoplasm | Phase 1, Phase 2 | Status: COMPLETED